9qqebrszs26xzrihmdrc logo sigle

Stem Genomics

5 Orders Completed
IRMB - Hopital St Eloi, FR

About Stem Genomics

Stem Genomics provides specific services to assess the genetic integrity of stem cells. We propose a new test that allows detecting more than 90% of recurrent genomic abnormalities in pluripotent stem cells, the most worrying ones. The iCS-digital test (in Culture Supernatant-digital PCR test) is a rapid, sensitive, high-resolution, simple to interpret and cost-effective assay for the routine testing of your stem cells in culture. This new test is particularly suitable for screening genetically stable clones, for instance patient-derived induced pluripotent stem cell clones after reprogramming or after CRISPR-based editing. Stem Genomics develops a technology invented by Prof John De Vos and Dr Said Assou, researchers at the Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, and co-founders of the company. Located at the heart of the University Hospital Centre of Montpellier, IRMB houses research groups working on basic stem cell research and on innovative applications for regenerative therapy, with the aim of facilitating the transfer from research to clinical applications. Stem Genomics is located at the IRMB Cyborg business incubator and works in close collaboration with IRMB researchers. Stem Genomics has emerged from a prestigious scientific environment. Details: Nicolas Chapal President and CEO Stem Genomics SAS Mob +33 6 42 11 24 24 Institute for Regenerative Medicine and Biotherapy Hopital Saint Eloi 80 avenue Augustin Fliche 34090 Montpellier France www.stemgenomics.com

Our Services (1)


ic

Stem Cell Analysis and Characterization

Price on request

The in Culture Supernatant-digital PCR Pluri (iCS-digital Pluri) test detects more than 90% of recurrent genomic abnormalities in human pluripotent stem cells (PSC), i.e. human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC). See: http://stemgenomics.com/ics-digital-tm-pluri

The in Culture Supernatant-digital PCR Aneuploidy (iCS-digital Aneuploidy) test detects whole chromosome gains & losses in all chromosomes (22 autosome pairs and X and Y chromosomes) and in any human cell type. See: http://stemgenomics.com/ics-digital-tm-aneuploidy

Taking advantage on its own experience and skills, Stem Genomics can also design and run customized assays to meet your specific requirement.

Genomics ddPCR digital PCR Genetic Stability CNV cell culture supernatant Cells DNA gDNA Human Show 10 more tags Show less

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.

FileType/PDF Created with Sketch. Stem Genomics_iCS-digital_Sample collection instructions.pdf

Click to Download

FileType/Other Created with Sketch. Stem Genomics_Sample release form.xlsx

Click to Download
  • Positive review for Stem Cell Analysis and Characterization:

    February 2020

    "Yes. The company works very profesional with high standards and the communication and delivery of the results is extremly fast and excellent. I can only recommend theier service. Best regards Klaus Christensen"

  • Positive review for Stem Cell Analysis and Characterization:

    August 2019

    "Yes, certainly. They provide this service very fast in a very professional matter. The company is very responsive and proactive with every project we had with the company. The performance is outstanding. Best regards Klaus Christensen F.Hoffmann-La Roche Basel Ltd."

  • Positive review for Stem Cell Analysis and Characterization:

    July 2019

    "Yes, certainly. Fast and efficient service. Best regards Klaus"

Stem Genomics has not received any endorsements.